• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺含铁血黄素沉着症中的脂质代谢受损。

Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.

机构信息

Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

出版信息

Lipids Health Dis. 2011 Apr 12;10:54. doi: 10.1186/1476-511X-10-54.

DOI:10.1186/1476-511X-10-54
PMID:21486485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098173/
Abstract

BACKGROUND

It is well known that lipids abnormally accumulate in the alveoli during idiopathic pulmonary alveolar proteinosis (PAP). It is unclear, however, whether lipids also abnormally accumulate in serum. This study investigated the serum lipid panels in idiopathic PAP patients and explored the relationships between serum levels and the severity of idiopathic PAP.

METHODS AND RESULTS

Clinical data including the level of serum lipids were evaluated in 33 non-diabetic idiopathic PAP patients and 157 healthy volunteers. Serum levels of triglyceride were higher in PAP patients than in healthy subjects (median: 192.00 mg/dl (P25: 104.36, P75: 219.00) vs 119.56 mg/dl (P25: 78.81, P75: 193.03), P < 0.05), while high-density lipoprotein cholesterol (HDL-C) levels were lower in patients than in the control group (42.50 ± 10.30 vs 51.34 ± 12.06 mg/dl, P < 0.01). Forced expiratory volume in one second and forced vital capacity in hypertriglyceridemia patients were lower than those in patients with normal triglyceride. Serum LDL-C and HDL-C ratio correlated negatively with PaO2 (r = -0.403, P < 0.05) and positively with lactate dehydrogenase (r = 0.381, P < 0.05).

CONCLUSIONS

PAP associates with high triglyceride and low HDL levels in the serum, and these lipids provide potential intervention strategy for treatment.

摘要

背景

特发性肺泡蛋白沉积症(PAP)患者的肺泡中异常积聚脂质是众所周知的。然而,目前尚不清楚血清中是否也异常积聚脂质。本研究调查了特发性 PAP 患者的血清脂质谱,并探讨了血清水平与特发性 PAP 严重程度之间的关系。

方法和结果

评估了 33 例非糖尿病特发性 PAP 患者和 157 名健康志愿者的临床数据,包括血清脂质水平。PAP 患者的血清甘油三酯水平高于健康对照组(中位数:192.00mg/dl(P25:104.36,P75:219.00)比 119.56mg/dl(P25:78.81,P75:193.03),P<0.05),而高密度脂蛋白胆固醇(HDL-C)水平低于对照组(42.50±10.30 vs 51.34±12.06mg/dl,P<0.01)。在高甘油三酯血症患者中,一秒用力呼气容积和用力肺活量均低于正常甘油三酯患者。血清 LDL-C 和 HDL-C 比值与 PaO2 呈负相关(r=-0.403,P<0.05),与乳酸脱氢酶呈正相关(r=0.381,P<0.05)。

结论

PAP 与血清中高甘油三酯和低 HDL 水平相关,这些脂质为治疗提供了潜在的干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/3098173/2b70409cf38b/1476-511X-10-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/3098173/2b70409cf38b/1476-511X-10-54-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/3098173/2b70409cf38b/1476-511X-10-54-1.jpg

相似文献

1
Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.特发性肺含铁血黄素沉着症中的脂质代谢受损。
Lipids Health Dis. 2011 Apr 12;10:54. doi: 10.1186/1476-511X-10-54.
2
Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis.特发性肺肺泡蛋白沉积症患者血清脂质的临床意义。
Lipids Health Dis. 2012 Jan 17;11:12. doi: 10.1186/1476-511X-11-12.
3
Characteristics of serum lipid metabolism in patients with autoimmune pulmonary alveolar proteinosis.自身免疫性肺泡蛋白沉积症患者的血清脂质代谢特征
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Dec;36(6):645-9. doi: 10.3881/j.issn.1000-503X.2014.06.016.
4
Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population.韩国人群特发性肺肺泡蛋白沉积症的临床特征和结局。
J Korean Med Sci. 2010 Mar;25(3):393-8. doi: 10.3346/jkms.2010.25.3.393. Epub 2010 Feb 17.
5
Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study.脂质代谢在肺泡蛋白沉积症中的因果作用:一项观察性和孟德尔随机化研究
Thorax. 2024 Jan 18;79(2):135-143. doi: 10.1136/thorax-2023-220789.
6
Valuable Serum Markers in Pulmonary Alveolar Proteinosis.肺泡蛋白沉积症中的有价值血清标志物。
Dis Markers. 2019 Nov 11;2019:9709531. doi: 10.1155/2019/9709531. eCollection 2019.
7
Correlation Analysis and Intervention Study on Disturbance of Lipid Metabolism and Diabetic Peripheral Neuropathy.血脂代谢紊乱与糖尿病周围神经病变的相关性分析及干预研究。
Comput Math Methods Med. 2022 Feb 22;2022:2579692. doi: 10.1155/2022/2579692. eCollection 2022.
8
Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.
Respiration. 1995;62(6):317-21. doi: 10.1159/000196473.
9
[The pulmonary expression of granulocyte-macrophage colony-stimulating factor and surfactant protein in adult idiopathic pulmonary alveolar proteinosis].[成人特发性肺泡蛋白沉积症中粒细胞巨噬细胞集落刺激因子和表面活性物质蛋白的肺表达]
Zhonghua Nei Ke Za Zhi. 2005 Nov;44(11):832-5.
10
Correlation of Lipid Ratios With the Severity of Pulmonary Alveolar Proteinosis: A Cross-Sectional Study.脂质比率与肺泡蛋白沉积症严重程度的相关性:一项横断面研究。
Front Nutr. 2021 Mar 18;8:610765. doi: 10.3389/fnut.2021.610765. eCollection 2021.

引用本文的文献

1
Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies.肺泡蛋白沉积症中的肺泡巨噬细胞:起源、功能和治疗策略。
Front Immunol. 2023 Jun 14;14:1195988. doi: 10.3389/fimmu.2023.1195988. eCollection 2023.
2
Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study.评估无高胆固醇血症的肺泡蛋白沉积症的他汀类药物治疗:一项为期 12 个月的前瞻性、纵向、观察性研究。
Biomed Res Int. 2022 Oct 25;2022:1589660. doi: 10.1155/2022/1589660. eCollection 2022.
3
Correlation of Lipid Ratios With the Severity of Pulmonary Alveolar Proteinosis: A Cross-Sectional Study.

本文引用的文献

1
Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice.过表达 PPARγ 可逆转 GM-CSF 敲除小鼠肺泡巨噬细胞中的脂质堆积。
Am J Physiol Lung Cell Mol Physiol. 2011 Jan;300(1):L73-80. doi: 10.1152/ajplung.00128.2010. Epub 2010 Oct 29.
2
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.吸入粒细胞/巨噬细胞集落刺激因子治疗肺泡蛋白沉积症。
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18.
3
Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.
脂质比率与肺泡蛋白沉积症严重程度的相关性:一项横断面研究。
Front Nutr. 2021 Mar 18;8:610765. doi: 10.3389/fnut.2021.610765. eCollection 2021.
4
Pulmonary alveolar proteinosis in Korea: analysis of prevalence and incidence via a nationwide population-based study.韩国的肺泡蛋白沉积症:一项全国性基于人群的研究分析患病率和发病率。
BMC Pulm Med. 2020 Feb 6;20(1):34. doi: 10.1186/s12890-020-1074-5.
5
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis.他汀类药物作为一种新型的肺泡蛋白沉积症的药物治疗方法。
Nat Commun. 2018 Aug 7;9(1):3127. doi: 10.1038/s41467-018-05491-z.
6
Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis.特发性肺肺泡蛋白沉积症患者血清脂质的临床意义。
Lipids Health Dis. 2012 Jan 17;11:12. doi: 10.1186/1476-511X-11-12.
人粒细胞-巨噬细胞集落刺激因子自身抗体与肺泡蛋白沉积症的复发
N Engl J Med. 2009 Dec 31;361(27):2679-81. doi: 10.1056/NEJMc0904077.
4
Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.肺泡蛋白沉积症综合征:发病机制、诊断与治疗
Curr Opin Pulm Med. 2009 Sep;15(5):491-8. doi: 10.1097/MCP.0b013e32832ea51c.
5
Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.双重过氧化物酶体增殖物激活受体α/γ激动剂阿格列扎对2型糖尿病患者心血管疾病风险的影响(同步研究):一项II期随机剂量范围研究
Lancet. 2009 Jul 11;374(9684):126-35. doi: 10.1016/S0140-6736(09)60870-9. Epub 2009 Jun 8.
6
Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.两名自身免疫性肺泡蛋白沉积症青少年对雾化粒细胞-巨噬细胞集落刺激因子纵向反应的定量分析。
Chest. 2009 Mar;135(3):842-848. doi: 10.1378/chest.08-1317.
7
Insulin resistance in pulmonary arterial hypertension.肺动脉高压中的胰岛素抵抗
Eur Respir J. 2009 Feb;33(2):318-24. doi: 10.1183/09031936.00000508. Epub 2008 Dec 1.
8
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?纤维化性肺病中的类二十烷酸脂质介质:准备好进入黄金时代了吗?
Chest. 2008 Jun;133(6):1442-1450. doi: 10.1378/chest.08-0306.
9
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.日本一大群自身免疫性肺泡蛋白沉积症患者的特征。
Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. doi: 10.1164/rccm.200708-1271OC. Epub 2008 Jan 17.
10
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.ABCG1在GM-CSF基因敲除小鼠和肺泡蛋白沉积症患者的肺泡巨噬细胞中缺乏。
J Lipid Res. 2007 Dec;48(12):2762-8. doi: 10.1194/jlr.P700022-JLR200. Epub 2007 Sep 11.